Midatro Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Ipratropium Br

Indications/Uses

As a bronchodilator to prevent & treat the symptoms of reversible COPD eg, bronchial asthma & chronic bronchitis w/ or w/o emphysema.

Dosage/Direction for Use

Adult (including elderly) & adolescence >14 yr 0.4-2 mL 3-4 times daily. Childn 6-14 yr 0.4-1 mL 3-4 times daily. All doses should be diluted w/ physiologic saline to a final vol of 3-4 mL & nebulized & inhaled until the soln is consumed.

Contraindications

Hypersensitivity to atropine or any other components of Midatro.

Special Precautions

Patients w/ narrow angle glaucoma, prostate hypertrophy, bladder neck obstruction. Patients w/ glaucoma tendency. Pregnancy & lactation. Childn <12 yr.

Adverse Reactions

GI motility disturbance (eg, constipation, diarrhea, vomiting), dry mouth, headache, increased heart beat, palpitation, supraventricular tachycardia, atrial fibrillation, accommodation disorders, urinary retention, cough, local irritation, bronchospasms, allergic reactions (skin redness, angioedema of the tongue, lips & face, urticarial, laryngospasms, anaphylactic reactions.

View ADR Monitoring Form

Drug Interactions

May enhance bronchodilatation effect w/ β-adrenergic & xanthine. Increased the risk of acute glaucoma.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03BB01 - ipratropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.

Regulatory Classification

Presentation/Packing

Form

Midatro inhalation soln 0.25 mg/mL

Packing/Price

2 mL x 10 × 1's

Midatro

ipratropium bromide

Manufacturer:

Fahrenheit